BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 29712662)

  • 21. Analyzing pmrA and pmrB genes in Acinetobacter baumannii resistant to colistin in Shahid Rajai Shiraz, Iran Hospital by PCR: First report in Iran.
    Sepahvand S; Doudi M; Davarpanah MA; Bahador A; Ahmadi M
    Pak J Pharm Sci; 2016 Jul; 29(4 Suppl):1401-6. PubMed ID: 27592491
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Growth retardation, reduced invasiveness, and impaired colistin-mediated cell death associated with colistin resistance development in Acinetobacter baumannii.
    Pournaras S; Poulou A; Dafopoulou K; Chabane YN; Kristo I; Makris D; Hardouin J; Cosette P; Tsakris A; Dé E
    Antimicrob Agents Chemother; 2014; 58(2):828-32. PubMed ID: 24247145
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic and virulence characterization of colistin-resistant and colistin-sensitive A. baumannii clinical isolates.
    Leite GC; Stabler RA; Neves P; Perdigão Neto LV; Ruedas Martins RC; Rizek C; Rossi F; Levin AS; Costa SF
    Diagn Microbiol Infect Dis; 2019 Sep; 95(1):99-101. PubMed ID: 31178071
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Contribution of EmrAB efflux pumps to colistin resistance in Acinetobacter baumannii.
    Lin MF; Lin YY; Lan CY
    J Microbiol; 2017 Feb; 55(2):130-136. PubMed ID: 28120193
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rapid detection of colistin resistance in Acinetobacter baumannii using MALDI-TOF-based lipidomics on intact bacteria.
    Dortet L; Potron A; Bonnin RA; Plesiat P; Naas T; Filloux A; Larrouy-Maumus G
    Sci Rep; 2018 Nov; 8(1):16910. PubMed ID: 30442963
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic alterations in the pmrAB two-component system and lipid A biosynthesis genes of polymyxin-resistant Acinetobacter baumannii isolates.
    El Mrimar N; Belouad EM; Benaissa E; Bssaibis F; Jazouli M; El Alaoui MA; Maleb A; Elouennass M
    Acta Microbiol Immunol Hung; 2024 Jul; 71(2):134-139. PubMed ID: 38837239
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Resistance to colistin in Acinetobacter baumannii associated with mutations in the PmrAB two-component system.
    Adams MD; Nickel GC; Bajaksouzian S; Lavender H; Murthy AR; Jacobs MR; Bonomo RA
    Antimicrob Agents Chemother; 2009 Sep; 53(9):3628-34. PubMed ID: 19528270
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genomic characterization of extensively drug-resistant Acinetobacter baumannii strain, KAB03 belonging to ST451 from Korea.
    Lee SY; Oh MH; Yun SH; Choi CW; Park EC; Song HS; Lee H; Yi YS; Shin J; Chung C; Moon JY; Lee JC; Kim GH; Kim SI
    Infect Genet Evol; 2018 Nov; 65():150-158. PubMed ID: 30053642
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Contribution of Novel Amino Acid Alterations in PmrA or PmrB to Colistin Resistance in
    Sato T; Shiraishi T; Hiyama Y; Honda H; Shinagawa M; Usui M; Kuronuma K; Masumori N; Takahashi S; Tamura Y; Yokota SI
    Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29914952
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trajectory of genetic alterations associated with colistin resistance in Acinetobacter baumannii during an in-hospital outbreak of infection.
    Yoon EJ; Kim HS; Woo H; Choi YJ; Won D; Choi JR; Kim YA; Jeong SH
    J Antimicrob Chemother; 2021 Dec; 77(1):69-73. PubMed ID: 34609499
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical and laboratory-induced colistin-resistance mechanisms in Acinetobacter baumannii.
    Boinett CJ; Cain AK; Hawkey J; Do Hoang NT; Khanh NNT; Thanh DP; Dordel J; Campbell JI; Lan NPH; Mayho M; Langridge GC; Hadfield J; Chau NVV; Thwaites GE; Parkhill J; Thomson NR; Holt KE; Baker S
    Microb Genom; 2019 Feb; 5(2):. PubMed ID: 30720421
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synergy between Colistin and the Signal Peptidase Inhibitor MD3 Is Dependent on the Mechanism of Colistin Resistance in Acinetobacter baumannii.
    Martínez-Guitián M; Vázquez-Ucha JC; Odingo J; Parish T; Poza M; Waite RD; Bou G; Wareham DW; Beceiro A
    Antimicrob Agents Chemother; 2016 Jul; 60(7):4375-9. PubMed ID: 27139471
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Emergence of Colistin- and Carbapenem-Resistant Acinetobacter baumannii ST2 Clinical Isolate in Algeria: First Case Report.
    Bakour S; Olaitan AO; Ammari H; Touati A; Saoudi S; Saoudi K; Rolain JM
    Microb Drug Resist; 2015 Jun; 21(3):279-85. PubMed ID: 25588125
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Retained colistin susceptibility in clinical
    Zafer MM; Hussein AFA; Al-Agamy MH; Radwan HH; Hamed SM
    Front Cell Infect Microbiol; 2023; 13():1229473. PubMed ID: 37600939
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of Genes Involved in Colistin Resistance in
    Al-Kadmy IMS; Ibrahim SA; Al-Saryi N; Aziz SN; Besinis A; Hetta HF
    Microb Drug Resist; 2020 Jun; 26(6):616-622. PubMed ID: 31816255
    [No Abstract]   [Full Text] [Related]  

  • 36. Molecular characterisation of colistin and carbapenem-resistant clinical isolates of Acinetobacter baumannii from Southeast Europe.
    Goic-Barisic I; Music MS; Drcelic M; Tuncbilek S; Akca G; Jakovac S; Tonkić M; Hrenovic J
    J Glob Antimicrob Resist; 2023 Jun; 33():26-30. PubMed ID: 36878462
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contribution of efflux to colistin heteroresistance in a multidrug resistant Acinetobacter baumannii clinical isolate.
    Machado D; Antunes J; Simões A; Perdigão J; Couto I; McCusker M; Martins M; Portugal I; Pacheco T; Batista J; Toscano C; Viveiros M
    J Med Microbiol; 2018 Jun; 67(6):740-749. PubMed ID: 29717972
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In Vitro Interactions of Antibiotic Combinations of Colistin, Tigecycline, and Doripenem Against Extensively Drug-Resistant and Multidrug-Resistant Acinetobacter baumannii.
    Park GC; Choi JA; Jang SJ; Jeong SH; Kim CM; Choi IS; Kang SH; Park G; Moon DS
    Ann Lab Med; 2016 Mar; 36(2):124-30. PubMed ID: 26709259
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phenotypic changes associated with Colistin resistance due to Lipopolysaccharide loss in Acinetobacter baumannii.
    Carretero-Ledesma M; García-Quintanilla M; Martín-Peña R; Pulido MR; Pachón J; McConnell MJ
    Virulence; 2018 Dec; 9(1):930-942. PubMed ID: 29638177
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Emergence of colistin-resistant Acinetobacter modestus harbouring the intrinsic phosphoethanolamine transferase EptA.
    Sakuma M; Hashimoto M; Nishi K; Tohya M; Hishinuma T; Shimojima M; Tada T; Kirikae T
    J Glob Antimicrob Resist; 2023 Jun; 33():101-108. PubMed ID: 36906175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.